Top Markets
#1 MowCat MowCat +48.69%
#2 Bermuda Shorts Bermuda Shorts +30.68%
#3 Biconomy Biconomy +26.35%
#4 Velvet Velvet +23.94%
#5 Quack AI Quack AI +20.15%
#6 Derive Derive +16.90%
#7 DUSK Network DUSK Network +13.76%
#8 Zerebro Zerebro +13.35%
#9 Block Street Block Street +13.19%
#10 Perle Perle +12.91%
Coin of the day
MowCat MowCat
설정
언어
한국어
통화
USD
테마
Imunon, Inc. Imunon, Inc.

Imunon, Inc.

CLSN
주식 순위 #35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
주가
$1.96
마지막 동기화: 2022-09-20
시가총액
$4.46M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Imunon, Inc. (CLSN)

카테고리

Healthcare
Imunon, Inc. (CLSN)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Imunon, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Imunon, Inc.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE